Variability of Insulin Absorption and Insulin Action
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Subcutaneous (s.c.) injections of identical insulin doses may lead to considerable intra- and inter-individual differences in the current metabolic control of patients with diabetes mellitus. This well-known variability of the metabolic effect of insulin hampers practical insulin therapy considerably. The aim of this review is to summarize the knowledge about this topic, with a special focus on the variability of insulin action after pulmonary administration of insulin. A number of studies have been published describing the variability of insulin absorption from the s.c. depot. Only in a few published studies has the variability of insulin action after s.c. administration been quantified. Under controlled experimental conditions s.c. injections of regular insulins result in an intra-individual coefficient of variation (CV) of 15-25% of certain pharmacodynamic summary measures--which characterize the metabolic effect of the applied insulin--in healthy subjects. The inter-individual variability was approximately 10% higher than the intra-individual variability. Subcutaneously injected intermediate- and long-acting insulin preparations were described to have an even greater variability (> 50%) than subcutaneously injected regular insulin. However, in a glucose clamp study s.c. application of NPH insulin led to an intra-individual CV in the range of 12-45% in healthy subjects. The reason for this discrepancy might be that the NPH insulin suspension was sufficiently shaken prior to drawing up the dose. Compared with conventional insulin formulations, rapid- and long-acting insulin analogues appear to have a similar variability, which means that, unfortunately, no considerable advantages in terms of variability were achieved by the invention of these novel insulin preparations. There are no appropriate studies available investigating the variability of the metabolic effect after s.c. insulin administration in patients with diabetes. The inhalation of insulin is a novel form of insulin administration that is currently under clinical development. The variability of the metabolic effect induced by the inhalation of insulin has up to now only been investigated in a small number of (published) studies. In a glucose-clamp study with healthy subjects the inhalation of an identical insulin dose on three study days led to an intra-individual variability that was comparable to that after s.c. injection of regular insulin. In a dose-response study with patients with type 1 diabetes the intra-individual CV was 34% for the area under the curve of the glucose infusion rate for 0-10 h. Studies with patients with type 2 diabetes have shown that the intra-individual CVs were within the range seen after s.c. insulin administration or even lower. In summary, the intra-individual variability of the metabolic effect observed after insulin application, be it subcutaneously injected or be it inhaled, is considerable and, therefore, hampers practical diabetes therapy. To date no means have been found that could lead to a clinically relevant reduction in the variable metabolic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this approach increases the risk of hypoglycemia if emptying accelerates unpredictably or hyperglycemia if the delay worsens [113, 114].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [113]
In the citing paper
“In consistently slow gastric emptying, switching from rapid-acting insulin analogues to regular human insulin may be beneficial, as its slower onset (30–60 min) and longer duration (6–8 h) can better match the delayed absorption of carbohydrates [3, 14, 92, 113, 114].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [113]
In the citing paper
“The mechanisms that cause variable and unreliable insulin absorption from a CSII catheter into the circulation are poorly understood.”
From Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine (2017) · cites this paper as [11]
Citations
Cites
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Binder, C., Lauritzen, T., Faber, O., & Pramming, S. (1984) · Diabetes Care · doi:10.2337/diacare.7.2.188 · Cited by 341
Absorption of Injected Insulin: A Clinical‐Pharmacological Study
BINDER, C. (1969) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1969.tb03069.x · Cited by 287
Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations
Berger, M., Cüppers, H. J., Hegner, H., Jörgens, V, & Berchtold, P. (1982) · Diabetes Care · doi:10.2337/diacare.5.2.77 · Cited by 252
Galloway, J. A., Spradlin, C. T., Nelson, R. L., Wentworth, S. M., Davidson, J. A., & Swarner, J. L. (1981) · Diabetes Care · doi:10.2337/diacare.4.3.366 · Cited by 226
Patton, J. S., Bukar, J., & Nagarajan, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00074-x · Cited by 193
Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
Jehle, P. M., Micheler, C., Jehle, D. R., Breitig, D., & Boehm, B. O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12459-5 · Cited by 186
Heinemann, L., Weyer, C., Rauhaus, M., Heinrichs, S., & Heise, T. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1910 · Cited by 163
Self-citationTime‐action profile of the soluble, fatty acid acylated, long‐acting insulin analogue NN304
Heinemann, L., Sinha, K., Weyer, C., Loftager, M., Hirschberger, S., & Heise, T. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00081.x · Cited by 158
Self-citationDanne, T., Lüpke, K., Walte, K., von Schuetz, W., & Gall, M.-A. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3087 · Cited by 153
Research works printed but not linked: 6
- Antsiferov M, 1995, Diabetologia, 38, 733
- Galloway JA, 1986, Amsterdam: Excerpta Medica, 877
- Scholtz HE, 1999, Diabetologia, 42, A235
- Perea AD, 2001, Diabetologia, 44, A212
- Strange P, 1999, Diabetes, 8, A103
- Vignati L, 1995, Diabetologia, 38, 737
Cited by
Heise, T., Nosek, L., Rønn, B. B., Endahl, L., Heinemann, L., Kapitza, C., & Draeger, E. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1614 · Cited by 614
Self-citationInsulin‐associated weight gain in diabetes – causes, effects and coping strategies
Russell‐Jones, D., & Khan, R. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00686.x · Cited by 557
Closed-loop insulin delivery from bench to clinical practice
Hovorka, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.32 · Cited by 342
Closed-loop insulin delivery—the path to physiological glucose control
Steil, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.011 · Cited by 313
Gibney, M. A., Arce, C. H., Byron, K. J., & Hirsch, L. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.481203 · Cited by 283
Metadata
- Authors
- Heinemann, L.
- Affiliations
- Profil Institute for Metabolic Research (DE)
- Corresponding author
- Heinemann, Lutz
- ORCID
- Heinemann, Lutz
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2002-10
- Volume
- 4
- Issue
- 5
- Pages
- 673-682
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2008449957
- Cited by
- 267
- References
- 26
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 6 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 10 · 2019: 7 · 2018: 9 · 2017: 15 · 2016: 6 · 2015: 17 · 2014: 11 · 2013: 6 · 2012: 21
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Diabetes Technology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- insulin action, insulin absorption, subcutaneous insulin administration, pulmonary insulin delivery, insulin analogues, NPH insulin, long-acting insulin, type 1 diabetes, type 2 diabetes, glucose clamp, coefficient of variation, interindividual variability, within-person variability, insulin pharmacodynamics, insulin therapy, dose-response relationship, glycemic control
- MeSH terms
- Administration, Inhalation, Blood Glucose, Diabetes Mellitus, Humans, Injections, Subcutaneous, Insulin, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variability of Insulin Absorption and Insulin Action. https://app.cochat.ai/papers/10.1089/152091502320798312
- The paper
- Heinemann, L. (2002). Variability of Insulin Absorption and Insulin Action. Diabetes Technology & Therapeutics. https://doi.org/10.1089/152091502320798312
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.